SciELO - Scientific Electronic Library Online

 
vol.41 issue1Incorporation of the study of quality of life to clinical trials: recommendations for its useSynercidâ: a combination of streptogramins A and B for the treatment of grampositive multiresistant pathogens author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Farmacia

On-line version ISSN 1561-2988

Abstract

MACHADO RIVERO, Manuel Osvaldo. Synercidâ: a combination of streptogramins A and B for the treatment of grampositive multiresistant pathogens. Rev Cubana Farm [online]. 2007, vol.41, n.1, pp. 0-0. ISSN 1561-2988.

A review of the articles published on streptogramins, a family of antimicrobials to treat the sepsis caused by grampositive germs, was made. The main characteristics and use of quinupristine and dalfopristine, active principles of Synercid®, were exposed. T his drug is an alternative for the treatment of grampositive strains resistant to glucopeptides.

Keywords : Synercid; streptogramins; quinupristine; dalfopristrine; antimicrobials; antibiotics; grampositive.

        · abstract in Spanish     · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License